Batchu, S.N.; Yerra, V.G.; Liu, Y.; Advani, S.L.; Klein, T.; Advani, A.
The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Directly Enhances the Contractile Recovery of Mouse Hearts at a Concentration Equivalent to that Achieved with Standard Dosing in Humans. Int. J. Mol. Sci. 2020, 21, 5756.
https://doi.org/10.3390/ijms21165756
AMA Style
Batchu SN, Yerra VG, Liu Y, Advani SL, Klein T, Advani A.
The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Directly Enhances the Contractile Recovery of Mouse Hearts at a Concentration Equivalent to that Achieved with Standard Dosing in Humans. International Journal of Molecular Sciences. 2020; 21(16):5756.
https://doi.org/10.3390/ijms21165756
Chicago/Turabian Style
Batchu, Sri Nagarjun, Veera Ganesh Yerra, Youan Liu, Suzanne L. Advani, Thomas Klein, and Andrew Advani.
2020. "The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Directly Enhances the Contractile Recovery of Mouse Hearts at a Concentration Equivalent to that Achieved with Standard Dosing in Humans" International Journal of Molecular Sciences 21, no. 16: 5756.
https://doi.org/10.3390/ijms21165756
APA Style
Batchu, S. N., Yerra, V. G., Liu, Y., Advani, S. L., Klein, T., & Advani, A.
(2020). The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Directly Enhances the Contractile Recovery of Mouse Hearts at a Concentration Equivalent to that Achieved with Standard Dosing in Humans. International Journal of Molecular Sciences, 21(16), 5756.
https://doi.org/10.3390/ijms21165756